KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Repligen (RGEN) Common Equity (2016 - 2025)

Historic Common Equity for Repligen (RGEN) over the last 16 years, with Q3 2025 value amounting to $2.1 billion.

  • Repligen's Common Equity rose 329.26% to $2.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 billion, marking a year-over-year increase of 329.26%. This contributed to the annual value of $2.0 billion for FY2024, which is 40.07% up from last year.
  • As of Q3 2025, Repligen's Common Equity stood at $2.1 billion, which was up 329.26% from $2.1 billion recorded in Q2 2025.
  • Over the past 5 years, Repligen's Common Equity peaked at $2.1 billion during Q3 2025, and registered a low of $1.6 billion during Q1 2021.
  • Over the past 5 years, Repligen's median Common Equity value was $2.0 billion (recorded in 2023), while the average stood at $1.9 billion.
  • Its Common Equity has fluctuated over the past 5 years, first soared by 5248.56% in 2021, then soared by 40.07% in 2024.
  • Quarter analysis of 5 years shows Repligen's Common Equity stood at $1.8 billion in 2021, then increased by 9.18% to $1.9 billion in 2022, then grew by 2.83% to $2.0 billion in 2023, then rose by 0.4% to $2.0 billion in 2024, then rose by 5.59% to $2.1 billion in 2025.
  • Its Common Equity stands at $2.1 billion for Q3 2025, versus $2.1 billion for Q2 2025 and $2.0 billion for Q1 2025.